Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Int J Med Inform. 2017 Jan 12;100:26–31. doi: 10.1016/j.ijmedinf.2017.01.006

Table 1.

Demographics and Selected Outcome Measures at Initial Visit

N (Female/Male) 31 (29/2)
Age, median (range) [IQR] 48 (27 – 61)
[44 – 56]
Years since onset, median (range) [IQR] 15.5 (4 – 37)
[10.25 – 19.75]
Years since diagnosis, median (range) [IQR] 12 (3 – 31)
[9.25 – 15]
MS Subtype:
  Relapsing-remitting disease 21
  Progressive disease 10
EDSS, median (range) [IQR] 3.5 (2 – 6.5)
[2.5 – 6]
PDDS, median (range) [IQR] 3 (0 – 7)
[1 – 4.5]
IADL Score, median (range) [IQR] 2 (0 – 9)
[0 – 4]
MSWS-12 Score, median (range) [IQR] 31.3 (0 – 100)
[8.9 – 79.7]
MFIS Total, median (range) [IQR] 36 (0 – 67)
[23 – 49]
T25FW, median (range) [IQR] 4.95 (3.3 – 67.4)
[3.9 – 12.7]

IQR: Inter-Quartile Range; MS: Multiple Sclerosis; EDSS: Expanded Disability Status Scale; PDDS: Patient Determined Disease Steps; IADL: Instrumental Activities of Daily Living; MSWS-12: MS Walking Scale; MFIS: Modified Fatigue Impact Scale; T25FW: Timed 25-Foot Walk